As the global population ages, the number of geriatric patients—those aged 65 and older—is rapidly increasing in almost every country. This change in population demographic will result in significant challenges to healthcare systems worldwide, particularly regarding the management of chronic diseases and the safe use of medications. One tool helping address that is now gaining momentum is ‘pharmacogenomic (PGx) testing’. This field, which combines pharmacology and genomics to deliver personalized medicine by tailoring drug therapies based on an individual’s genetic makeup. For geriatric patients, PGx testing is proving to be particularly transformative, and is demonstrated to improve patient quality of life through more effective and safer medication regimens.
Read more
Although giving birth is often described as one of the most beautiful experiences a woman can have, for many mothers, the period following childbirth can be marked by overwhelming emotions, fatigue, and, in some cases, postpartum depression (PPD). Postpartum depression is a serious condition that affects around one in seven women in the US after giving birth, and is characterized by feelings of sadness, anxiety, and exhaustion. While the exact causes of PPD are multifaceted and not fully understood, emerging research suggests that genetics plays a significant role in predisposing some women to this condition. But genetics may also hold the key to optimizing the use of medications to address this debilitating condition, and as new treatment options are approved by the FDA, there finally seems to be progress in this somewhat neglected field of medicine.
Read more
One of the most promising areas of precision medicine is the field of pharmacogenomics (PGx), a discipline that explores the relationship between an individual’s genetic makeup and their response to medications. While PGx has traditionally been associated with adult populations, its application in pediatric patients is becoming increasingly recognized as a valuable tool for guiding treatment decisions.
Read more
The role that oxidative stress plays in the development and progression of neurodegenerative diseases is well described and is now being translated into a source of novel therapeutic approaches. However, oxidative stress is also closely linked with the development and progression of many other chronic conditions, including one of the most prevalent, diabetes. The relationship between oxidative stress and diabetes involves complex interactions that contribute to insulin resistance, impaired glucose metabolism, inflammation, as well as many of the other complications associated with diabetes. In this blog, we review some of the most recent data describing the role of oxidative stress in diabetes and novel therapeutics that may help alleviate the burden of diabetes on our healthcare system.
Read more
Personalized medicine, also known as precision medicine, is a rapidly evolving approach to healthcare that can tailor treatment and prevention strategies to an individual’s specific genetic makeup, environment, and lifestyle. Unlike the traditional “one-size-fits-all” approach, it recognizes that we are all biologically unique, and what works for one person might not be optimal for another.
Read more
Pharmacogenomics, the study of how an individual’s genetic makeup influences drug responses, has ushered in a new era of personalized medicine. One of the areas most impacted by pharmacogenomics is within the field of clinical trials. Traditionally, clinical trials followed a one-size-fits-all approach, treating all patients as a homogeneous group. However, with the integration of pharmacogenomics, clinical trials have become more targeted and tailored, enabling researchers to identify subgroups of patients who are more likely to respond positively to specific treatments, and eliminating those at risk of adverse drug reaction.
Read more
Precision Medicine has become a widely used term in recent decades, and one of the most significant advancements supporting its use is the field of pharmacogenomics (PGx). At its core, PGx involves the study of how an individual’s genetic makeup influences their response to medications. This makeup is profiled by looking at the genes that encode the proteins involved in the absorption and metabolism of drugs. Based on these different genetic profiles we can better understand how an individual will respond to a particular therapeutic protocol. By tailoring drug therapies based on a person’s genetic profile, PGx is transforming the landscape of medicine, leading to more personalized, more effective, and safer treatments. In this blog, we will explore how PGx is revolutionizing healthcare and improving patient outcomes.
Read more
